Found 7 matching trials
Palopegteriparatide in Chronic Hypoparathyroidism N/A This is a multicenter, prospective cohort study conducted across 9 tertiary...
Show More Location
Laiko General Hospital
Learn More & Join Trial
PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism PHASE3 This study is limited to conduct in China only. The primary objective is to...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Cardiovascular Effects of Parathyroid Hormone Analogues in Chronic Hypoparathyroidism N/A The goal of this study is to evaluate cardiovascular effects of long-acting...
Show More Status
Active Not Recruiting
Location
Alexandra General Hospital of Athens
Learn More & Join Trial
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH Administered Daily in Adults With Hypoparathyroidism PHASE3 During the first 26 weeks of the trial, participants were randomly assigned...
Show More Location
Ascendis Pharma Investigational Site
Learn More & Join Trial
Expanded Access Program of Palopegteriparatide in Patients With Hypoparathyroidism N/A To provide palopegteriparatide (TransCon PTH), an investigational parathyro...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism PHASE2 During the first four weeks of the trial, participants were randomly assign...
Show More Location
Ascendis Pharma Investigational Site
Learn More & Join Trial
A Phase 3 Randomized Clinical Trial to Investigate the Safety and Efficacy of Palopegteriparatide at Doses Greater Than 30 μg/Day in Adult Participants With Hypoparathyroidism PHASE3 This trial has a treatment duration of 78 weeks and will include adult part...
Show More Location
Ascendis Pharma Investigational Site
Learn More & Join Trial